Nasdaq:US$15.11 (-0.09) | HKEX:HK$23.82 (-0.18) | AIM:£2.25 (+0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF